Skip to main content

Peer Review reports

From: Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study

Original Submission
28 Jun 2023 Submitted Original manuscript
24 Jul 2023 Reviewed Reviewer Report
18 Aug 2023 Reviewed Reviewer Report - Jorg R. Oddens
11 Oct 2023 Author responded Author comments - Yunkai Qie
Resubmission - Version 2
11 Oct 2023 Submitted Manuscript version 2
12 Oct 2023 Author responded Author comments - Yunkai Qie
Resubmission - Version 3
12 Oct 2023 Submitted Manuscript version 3
12 Oct 2023 Author responded Author comments - Yunkai Qie
Resubmission - Version 4
12 Oct 2023 Submitted Manuscript version 4
27 Oct 2023 Reviewed Reviewer Report - Jorg R. Oddens
29 Nov 2023 Reviewed Reviewer Report
30 Nov 2023 Reviewed Reviewer Report
22 Dec 2023 Author responded Author comments - Yunkai Qie
Resubmission - Version 5
22 Dec 2023 Submitted Manuscript version 5
23 Dec 2023 Author responded Author comments - Yunkai Qie
Resubmission - Version 6
23 Dec 2023 Submitted Manuscript version 6
26 Dec 2023 Author responded Author comments - Yunkai Qie
Resubmission - Version 7
26 Dec 2023 Submitted Manuscript version 7
28 Dec 2023 Reviewed Reviewer Report
28 Dec 2023 Reviewed Reviewer Report
2 Jan 2024 Reviewed Reviewer Report
5 Jan 2024 Reviewed Reviewer Report
8 Jan 2024 Author responded Author comments - Yunkai Qie
Resubmission - Version 8
8 Jan 2024 Submitted Manuscript version 8
15 Jan 2024 Reviewed Reviewer Report
15 Jan 2024 Reviewed Reviewer Report - Jorg R. Oddens
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
16 Jan 2024 Editorially accepted
31 Jan 2024 Article published 10.1186/s12894-024-01410-1

You can find further information about peer review here.

Back to article page